15 April 2026
EU Secures Preferential US Tariff Rates on Pharmaceuticals and Steel Amid 2026 Trade Policy Shifts
European Union Tariff News and Tracker
About
Welcome to European Union Tariff News and Tracker, listeners, where we break down the latest on US trade policies hitting Europe. As of mid-April 2026, President Trump's tariff landscape has stabilized after Supreme Court rulings struck down many broad levies, but the European Union remains in a preferential tier amid ongoing adjustments.
The White House's April 2 proclamation under Section 232 of the Trade Expansion Act restructured tariffs, explicitly naming the EU for reduced rates on key sectors. For patented pharmaceuticals and active pharmaceutical ingredients, EU-origin products face just a 15% ad valorem duty starting July 31, 2026, far below the default 100% applied to unlisted countries like China and India, according to the Clinical Leader report on the executive order. The United Kingdom gets an even lighter 10% on the same goods, while onshore plans can drop rates to 20% temporarily.
Steel tariffs saw revisions too: Global rates hit 50% on articles and 25% on derivatives, but the EU benefits from the broader framework deal elements implemented earlier, as tracked by Baker Botts' Trump Tariff Tracker on April 13. Average US tariffs now hover around 10-11%, per ISM's analysis of Liberation Day a year on, down from peaks but still pressuring supply chains—Yale Budget Lab estimates households face $760-940 extra annually if Section 122 surcharges hold until their July 24 expiry.
Refunds for struck-down IEEPA tariffs begin April 20 via Customs and Border Protection, totaling billions for importers, InsideTrade reports. Treasury Secretary Scott Bessent signaled at a Wall Street Journal event that pre-ruling rates could return by July via Section 301 studies, per Bloomberg Government, keeping EU exporters vigilant.
These EU-favorable tiers stem from the Implementing Elements of EU Framework Agreement, dodging the worst of reciprocal hikes that felled others. With pharma and metals in focus, Brussels watches for escalation amid global tensions.
Thanks for tuning in, listeners—subscribe for weekly updates on how US tariffs impact the EU. This has been a Quiet Please production, for more check out quietplease.ai.
For more check out https://www.quietperiodplease.com/
Avoid ths tariff fee's and check out these deals https://amzn.to/4iaM94Q
This content was created in partnership and with the help of Artificial Intelligence AI
This episode includes AI-generated content.
The White House's April 2 proclamation under Section 232 of the Trade Expansion Act restructured tariffs, explicitly naming the EU for reduced rates on key sectors. For patented pharmaceuticals and active pharmaceutical ingredients, EU-origin products face just a 15% ad valorem duty starting July 31, 2026, far below the default 100% applied to unlisted countries like China and India, according to the Clinical Leader report on the executive order. The United Kingdom gets an even lighter 10% on the same goods, while onshore plans can drop rates to 20% temporarily.
Steel tariffs saw revisions too: Global rates hit 50% on articles and 25% on derivatives, but the EU benefits from the broader framework deal elements implemented earlier, as tracked by Baker Botts' Trump Tariff Tracker on April 13. Average US tariffs now hover around 10-11%, per ISM's analysis of Liberation Day a year on, down from peaks but still pressuring supply chains—Yale Budget Lab estimates households face $760-940 extra annually if Section 122 surcharges hold until their July 24 expiry.
Refunds for struck-down IEEPA tariffs begin April 20 via Customs and Border Protection, totaling billions for importers, InsideTrade reports. Treasury Secretary Scott Bessent signaled at a Wall Street Journal event that pre-ruling rates could return by July via Section 301 studies, per Bloomberg Government, keeping EU exporters vigilant.
These EU-favorable tiers stem from the Implementing Elements of EU Framework Agreement, dodging the worst of reciprocal hikes that felled others. With pharma and metals in focus, Brussels watches for escalation amid global tensions.
Thanks for tuning in, listeners—subscribe for weekly updates on how US tariffs impact the EU. This has been a Quiet Please production, for more check out quietplease.ai.
For more check out https://www.quietperiodplease.com/
Avoid ths tariff fee's and check out these deals https://amzn.to/4iaM94Q
This content was created in partnership and with the help of Artificial Intelligence AI
This episode includes AI-generated content.